Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.
On a per-share basis, the Rahway, New Jersey-based company said it had profit of $1.48. Earnings, adjusted for one-time gains and costs, came to $1.72 per share. The results surpassed Wall Street ...
Reports Q4 revenue $15.6B, consensus $15.51B. “We delivered strong growth in 2024, reflecting demand for our innovative portfolio, including ...
Shares of Merck (NYSE: MRK) were trading lower on Tuesday. The drop comes as the S&P 500 gained 0.5% and the Nasdaq Composite ...
Merck MRK will report its fourth-quarter and full-year 2024 earnings on Feb. 4, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $15.56 billion and $1.72 per ...
15hon MSN
MRK provided 2025 adjusted EPS guidance of $8.88 to $9.03, while the giant drugmaker expects sales of $64.1 billion to $65.6 ...
Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset better-than-expected fourth-quarter earnings. Rahway, N.J.-based Merck had ...
With a market cap of $252.6 billion, Rahway, New Jersey-based Merck & Co., Inc. (MRK ... It is expected to unveil its fiscal Q4 earnings results before the market opens on Tuesday, Feb. 4.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback